Advertisement
Screener

Intuitive Surgical, Inc. (ISRG) Excess Tax Benefit from Share-based Compensation, Operating Activities

2.8 / 5 stars · 68/120 Roast Me

Intuitive Surgical, Inc. Excess Tax Benefit from Share-based Compensation, Operating Activities

Intuitive Surgical, Inc. (ISRG) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $44.10 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-06.

Discontinued › Notes › Compensation Related Costs

us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2017-02-06

  • Intuitive Surgical, Inc. excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-12-31 was $4.60M, a 318.18% increase year-over-year.
  • Intuitive Surgical, Inc. excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-09-30 was $9.20M, a 22.69% decline year-over-year.
  • Intuitive Surgical, Inc. excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-06-30 was $12.00M, a 8.11% increase year-over-year.
  • Intuitive Surgical, Inc. excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-03-31 was $18.30M, a 79.41% increase year-over-year.
  • Intuitive Surgical, Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2016 was $44.10M, a 28.57% increase from fiscal 2015.
  • Intuitive Surgical, Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2015 was $34.30M, a 42.92% increase from fiscal 2014.
  • Intuitive Surgical, Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2014 was $24.00M, a 36.84% decline from fiscal 2013.
  • Intuitive Surgical, Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2013 was $38.00M, a 59.66% decline from fiscal 2012.
Period endExcess Tax Benefit from Share-based Compensation, Operating Activities 3 monthExcess Tax Benefit from Share-based Compensation, Operating Activities 6 monthExcess Tax Benefit from Share-based Compensation, Operating Activities 6 month as first filedExcess Tax Benefit from Share-based Compensation, Operating Activities 9 monthExcess Tax Benefit from Share-based Compensation, Operating Activities 9 month as first filedExcess Tax Benefit from Share-based Compensation, Operating Activities 12 monthExcess Tax Benefit from Share-based Compensation, Operating Activities 12 month as first filed
2016-12-31$4.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-06
$13.80M
derived: sum of 2 quarters · filed 2017-02-06
$25.80M
derived: sum of 3 quarters · filed 2017-02-06
$44.10M
10-K · filed 2017-02-06
2016-09-30$9.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-19
$21.20M
derived: sum of 2 quarters · filed 2016-10-19
$39.50M
10-Q · filed 2016-10-19
$40.60M
derived: sum of 4 quarters · filed 2017-02-06
2016-06-30$12.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20
$30.30M
10-Q · filed 2016-07-20
$31.40M
derived: sum of 3 quarters · filed 2017-02-06
$43.30M
derived: sum of 4 quarters · filed 2017-02-06
2016-03-31$18.30M
10-Q · filed 2016-04-19
$19.40M
derived: sum of 2 quarters · filed 2017-02-06
$31.30M
derived: sum of 3 quarters · filed 2017-02-06
$42.40M
derived: sum of 4 quarters · filed 2017-02-06
2015-12-31$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-06
$13.00M
derived: sum of 2 quarters · filed 2017-02-06
$24.10M
derived: sum of 3 quarters · filed 2017-02-06
$34.30M
10-K · filed 2017-02-06
2015-09-30$11.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-19
$23.00M
derived: sum of 2 quarters · filed 2016-10-19
$33.20M
10-Q · filed 2016-10-19
$42.00M
derived: sum of 4 quarters · filed 2017-02-06
2015-06-30$11.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20
$21.30M
10-Q · filed 2016-07-20
$30.10M
derived: sum of 3 quarters · filed 2017-02-06
$39.20M
derived: sum of 4 quarters · filed 2017-02-06
2015-03-31$10.20M
10-Q · filed 2016-04-19
$19.00M
derived: sum of 2 quarters · filed 2017-02-06
$28.10M
derived: sum of 3 quarters · filed 2017-02-06
$29.90M
derived: sum of 4 quarters · filed 2017-02-06
2014-12-31$8.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-06
$17.90M
derived: sum of 2 quarters · filed 2017-02-06
$19.70M
derived: sum of 3 quarters · filed 2017-02-06
$24.00M
10-K · filed 2017-02-06
2014-09-30$9.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21
$10.90M
derived: sum of 2 quarters · filed 2015-10-21
$15.20M
10-Q · filed 2015-10-21
$22.10M
derived: sum of 4 quarters · filed 2016-02-02
2014-06-30$1.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-22
$6.10M
10-Q · filed 2015-07-22
$13.00M
derived: sum of 3 quarters · filed 2016-02-02
$17.60M
derived: sum of 4 quarters · filed 2016-02-02
2014-03-31$4.30M
10-Q · filed 2015-04-22
$11.20M
derived: sum of 2 quarters · filed 2016-02-02
$15.80M
derived: sum of 3 quarters · filed 2016-02-02
$21.70M
derived: sum of 4 quarters · filed 2016-02-02
2013-12-31$6.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-02
$11.50M
derived: sum of 2 quarters · filed 2016-02-02
$17.40M
derived: sum of 3 quarters · filed 2016-02-02
$38.00M
10-K · filed 2016-02-02
2013-09-30$4.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-23
$10.50M
derived: sum of 2 quarters · filed 2014-10-23
$31.10M
10-Q · filed 2014-10-23
$70.60M
derived: sum of 4 quarters · filed 2015-02-06
2013-06-30$5.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24
$26.50M
10-Q · filed 2014-07-24
$66.00M
derived: sum of 3 quarters · filed 2015-02-06
$76.00M
derived: sum of 4 quarters · filed 2015-02-06
2013-03-31$20.60M
10-Q · filed 2014-04-25
$60.10M
derived: sum of 2 quarters · filed 2015-02-06
$70.10M
derived: sum of 3 quarters · filed 2015-02-06
$94.60M
derived: sum of 4 quarters · filed 2015-02-06
2012-12-31$39.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06
$49.50M
derived: sum of 2 quarters · filed 2015-02-06
$74.00M
derived: sum of 3 quarters · filed 2015-02-06
$94.20M
10-K · filed 2015-02-06
2012-09-30$10.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-18
$34.50M
derived: sum of 2 quarters · filed 2013-10-18
$54.70M
10-Q · filed 2013-10-18
$68.60M
derived: sum of 4 quarters · filed 2014-02-03
2012-06-30$24.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-22
$44.70M
10-Q · filed 2013-07-22
$58.60M
derived: sum of 3 quarters · filed 2014-02-03
$79.10M
derived: sum of 4 quarters · filed 2014-02-03
2012-03-31$20.20M
10-Q · filed 2013-04-19
$34.10M
derived: sum of 2 quarters · filed 2014-02-03
$54.60M
derived: sum of 3 quarters · filed 2014-02-03
$65.30M
derived: sum of 4 quarters · filed 2014-02-03
2011-12-31$13.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-03
$34.40M
derived: sum of 2 quarters · filed 2014-02-03
$45.10M
derived: sum of 3 quarters · filed 2014-02-03
$58.80M
10-K · filed 2014-02-03
2011-09-30$20.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-18
$31.20M
derived: sum of 2 quarters · filed 2012-10-18
$44.90M
10-Q · filed 2012-10-18
$53.80M
derived: sum of 4 quarters · filed 2013-02-04
2011-06-30$10.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-23
$24.40M
10-Q · filed 2012-07-23
$33.30M
derived: sum of 3 quarters · filed 2013-02-04
$42.70M
derived: sum of 4 quarters · filed 2013-02-04
2011-03-31$13.70M
10-Q · filed 2012-04-19
$22.60M
derived: sum of 2 quarters · filed 2013-02-04
$32.00M
derived: sum of 3 quarters · filed 2013-02-04
$46.70M
derived: sum of 4 quarters · filed 2013-02-04
2010-12-31$8.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-04
$18.30M
derived: sum of 2 quarters · filed 2013-02-04
$33.00M
derived: sum of 3 quarters · filed 2013-02-04
$65.20M
10-K · filed 2013-02-04
2010-09-30$9.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-19
$24.10M
derived: sum of 2 quarters · filed 2011-10-19
$56.30M
10-Q · filed 2011-10-19
$72.20M
derived: sum of 4 quarters · filed 2012-02-06
2010-06-30$14.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-20
$46.90M
10-Q · filed 2011-07-20
$62.80M
derived: sum of 3 quarters · filed 2012-02-06
$71.00M
derived: sum of 4 quarters · filed 2012-02-06
2010-03-31$32.20M
10-Q · filed 2011-04-20
$48.10M
derived: sum of 2 quarters · filed 2012-02-06
$56.30M
derived: sum of 3 quarters · filed 2012-02-06
$57.30M
derived: sum of 4 quarters · filed 2012-02-06
2009-12-31$15.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-06
$24.10M
derived: sum of 2 quarters · filed 2012-02-06
$25.10M
derived: sum of 3 quarters · filed 2012-02-06
$25.10M
10-K · filed 2012-02-06
$25.14M
10-K · filed 2010-01-29
2009-09-30$8.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-20
$9.20M
derived: sum of 2 quarters · filed 2010-10-20
$9.20M
10-Q · filed 2010-10-20
$9.18M
10-Q · filed 2009-10-21
$9.71M
derived: sum of 4 quarters · filed 2011-02-01
2009-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-23
$1.00M
10-Q · filed 2010-07-23
$970.00K
10-Q · filed 2009-07-23
$1.51M
derived: sum of 3 quarters · filed 2011-02-01
$18.72M
derived: sum of 4 quarters · filed 2011-02-01
2009-03-31$0.00
10-Q · filed 2010-04-20
$509.00K
derived: sum of 2 quarters · filed 2011-02-01
$17.72M
derived: sum of 3 quarters · filed 2011-02-01
2008-12-31$509.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-01
$17.72M
derived: sum of 2 quarters · filed 2011-02-01
$53.30M
10-K · filed 2011-02-01
$53.30M
10-K · filed 2010-01-29
2008-09-30$17.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21
$52.79M
10-Q · filed 2009-10-21
2008-06-30$35.58M
10-Q · filed 2009-07-23
2007-12-31$62.87M
10-K · filed 2010-01-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Edwards Lifesciences Corp (EW)United States$49.409B51.96
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81